Sotera Health Appoints Christopher Simon to the Board of Directors

Core Insights - Sotera Health Company has appointed Christopher Simon as a new independent director to its Board of Directors, enhancing its leadership team [1][3] - Mr. Simon brings over 30 years of experience in the healthcare industry, including roles as President and CEO of Haemonetics Corporation and Senior Partner at McKinsey & Company [2][3] - Sotera Health operates through three business units: Sterigenics®, Nordion®, and Nelson Labs®, focusing on sterilization solutions and lab testing services for the healthcare sector [4] Company Overview - Sotera Health is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry [4] - The company is committed to its mission of "Safeguarding Global Health®" [4] Leadership Experience - Christopher Simon's leadership experience as a public company CEO and his strategic background in the life sciences industry are expected to be significant assets for Sotera Health's growth [3] - Mr. Simon also serves on the board of directors of AdvaMed, a global trade association for medical technology companies [3]